The Food and Drug Administration (FDA) has approved Zepbound ® (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity.
Black mothers are faced with a disproportionate number of barriers to breastfeeding compared to other racial and ethnic groups.
Dr. Renee Wynn is a doctorally educated, board-certified Women's Health Nurse Practitioner who focuses on perinatal and reproductive health justice. She is an Assistant Professor ...
As long as a drug shortage is declared, compounding pharmacies are still eligible to produce their own versions of Zepbound/Mounjaro. HealthDay News — The US Food and Drug Administration re ...
Credit: Celltrion Steqeyma, formerly known as CT-P43, is a human interleukin-12 and -23 antagonist. According to Celltrion, Steqeyma is expected to be available in February 2025. The Food and Drug ...
At least 61 human bird flu cases have been diagnosed in the United States this year, but this is the first requiring hospitalization. HealthDay News — In a case first reported in Louisiana last ...
Vitamin D supplementation, with or without calcium, offers no benefit for preventing falls or fractures in community-dwelling seniors and may increase risk of kidney stones. HealthDay News — The ...
Patients with a sepsis alert were more likely to have serum lactate tested and intravenous fluid ordered, reducing in-hospital mortality rates. HealthDay News — Electronic sepsis screening among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback